Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis.

Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA.

J Clin Endocrinol Metab. 2013 Jun;98(6):2409-14. doi: 10.1210/jc.2013-1309.

PMID:
23609834
2.

Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.

Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD.

Endocr Pathol. 2011 Sep;22(3):144-9. doi: 10.1007/s12022-011-9164-9.

PMID:
21647844
3.
4.

Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.

Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T.

Ann Surg Oncol. 2014 Aug;21(8):2725-32. doi: 10.1245/s10434-014-3593-x.

PMID:
24595799
5.

Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.

Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J.

Otolaryngol Head Neck Surg. 2013 Mar;148(3):396-402. doi: 10.1177/0194599812472426.

PMID:
23300224
6.

The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Zhang Y, Dai J, Wu T, Yang N, Yin Z.

J Cancer Res Clin Oncol. 2014 Jun;140(6):1021-6. doi: 10.1007/s00432-014-1629-z.

PMID:
24619663
7.

Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.

Lupoli GA, Okosieme OE, Evans C, Clark PM, Pickett AJ, Premawardhana LD, Lupoli G, Lazarus JH.

J Clin Endocrinol Metab. 2015 Jan;100(1):100-8. doi: 10.1210/jc.2014-2725.

PMID:
25322272
8.

Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer.

Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J.

Acta Oncol. 2011 Nov;50(8):1228-34. doi: 10.3109/0284186X.2011.602109.

PMID:
21871002
9.

Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer.

Ye ZQ, Gu DN, Hu HY, Zhou YL, Hu XQ, Zhang XH.

World J Surg Oncol. 2013 Mar 5;11:56. doi: 10.1186/1477-7819-11-56.

10.

[Influence of lymphocitic thyroiditis on prognostic outcome differentiated thyroid carcinoma].

Filipović A, Paunović I, Vucković Lj.

Acta Chir Iugosl. 2010;57(2):85-94. Serbian.

PMID:
20954315
11.

High rate of persistent/recurrent disease among patients with differentiated thyroid cancer in Saudi Arabia: factors affecting nonremission.

Raef H, Alfadhli E, Al-Hajjaj A, Malabu UH, Al-Sobhi S, Rifai A, Al Nuaim A.

Ann Saudi Med. 2008 Jul-Aug;28(4):277-81.

PMID:
18596397
12.

The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB.

Cancer. 1998 Jan 15;82(2):375-88.

PMID:
9445196
14.

Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.

Mihailovic J, Nikoletic K, Srbovan D.

J Nucl Med. 2014 May;55(5):710-7. doi: 10.2967/jnumed.113.130450.

15.

Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.

Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP.

J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62.

PMID:
9360506
16.

Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer.

Polachek A, Hirsch D, Tzvetov G, Grozinsky-Glasberg S, Slutski I, Singer J, Weinstein R, Shimon I, Benbassat CA.

J Endocrinol Invest. 2011 Dec;34(11):855-60. doi: 10.3275/7768.

PMID:
21646855
17.
18.

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2010 Apr;95(4):1516-27. doi: 10.1210/jc.2009-1536.

PMID:
20156922
19.

Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).

Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H.

Cancer. 1996 Jan 1;77(1):172-80.

20.

Treatment patterns of aging Americans with differentiated thyroid cancer.

Park HS, Roman SA, Sosa JA.

Cancer. 2010 Jan 1;116(1):20-30. doi: 10.1002/cncr.24717.

Supplemental Content

Support Center